Last year, I conducted a series of interviews with GPs in order to understand their experiences with anticoagulation management in patients with atrial fibrillation (AF). It is well known that AF is the most common arrhythmia seen in Australian general practice, and that the use of anticoagulants is a well-established intervention to reduce the risk of thromboembolism. This is reflected in the 2018 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand AF guidelines.
As such, I wanted to know more about GPs’ experiences with anticoagulation, and any barriers they may have with initiating anticoagulation. Below is what I found out from the research study:
For more information, see the published paper
If you are interested in the latest clinical updates on AF, and multiple other general practice topics, join us in February for our signature CPD program, the 2022 version of Hot Topics GP Update course.
Eyob Gebreyohannes (PhD candidate at the University of Western Australia – Optimising anticoagulation in atrial fibrillation in Australian general practice setting.)
BPharm, MSc, Ph.D. Candidate
Division of Pharmacy • School of Allied Health
Faculty of Health and Medical Sciences, University of Western Australia
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreGP Dr Rebecca Chan and Medical Director of Sexual Health Victoria Dr Sara Whitburn discuss the use of MHT in the perimenopause, covering regimen choice, bleeding expectations and long‑term management.
Minor procedures are part of a GP’s daily practice, yet MBS items are often not used correctly, risking non-compliance or missed revenue. This FastTrack provides a concise overview of common procedural item numbers in the MBS, including a refresher of key points to support billing compliance. 30mins each RP and EA available.
Tune in for the 'Ticker News' interview, Ahron Young and Dr Stephen Barnett discuss how AI is changing clinical practice in real time, from improving access to evidence at the point of care to the risks of misinformation and AI hallucinations. Dr. Barnett also discusses how MedLuma supports trusted clinical decision-making and the role organisations play in shaping standards as AI becomes embedded in healthcare.